Jiangsu Lianhuan Pharmaceutical Co., Ltd. (SHA:600513)

China flag China · Delayed Price · Currency is CNY
23.10
-0.38 (-1.62%)
Mar 10, 2026, 3:00 PM CST
142.90%
Market Cap 6.70B
Revenue (ttm) 2.60B
Net Income (ttm) -43.60M
Shares Out 285.46M
EPS (ttm) -0.15
PE Ratio n/a
Forward PE n/a
Dividend 0.09 (0.38%)
Ex-Dividend Date Jun 23, 2025
Volume 17,914,752
Average Volume 12,360,066
Open 23.24
Previous Close 23.48
Day's Range 22.51 - 23.49
52-Week Range 8.30 - 31.58
Beta 0.55
RSI 65.83
Earnings Date Apr 21, 2026

About SHA:600513

Jiangsu Lianhuan Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sells pharmaceuticals, preparations, and active pharmaceutical ingredients (API) products in China and internationally. The company offers clopidogrel bisulfate tablets, doxycycline hydrochloride, azithromycin, milrinone, dapoxetine hydrochloride, tadalafil, and betasine besylate tablets, as well as aprilite, danazol suppositories, and terfenadine tablets. It also provides urinary system drugs, including eprepitant tablets, terazosin tablets, and drotave... [Read more]

Sector Healthcare
Founded 1999
Employees 1,388
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 600513
Full Company Profile

Financial Performance

In 2024, SHA:600513's revenue was 2.16 billion, a decrease of -0.63% compared to the previous year's 2.17 billion. Earnings were 84.16 million, a decrease of -37.66%.

Financial Statements

News

There is no news available yet.